Hyderabad Telangana, India

Vemuri Venkata Suresh Babu

This inventor holds 1 USPTO granted patent. Top assignee: Natco Pharma Limited. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Vemuri Venkata Suresh Babu. Retrieved from https://idiyas.com/inventor/vemuri-venkata-suresh-babu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Vemuri Venkata Suresh Babu: Innovator in Pharmaceutical Compositions

Introduction

Vemuri Venkata Suresh Babu is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on stable pharmaceutical compositions.

Latest Patents

One of his key patents is titled "Stable pharmaceutical compositions comprising lenalidomide." This invention relates to pharmaceutical compositions that include Lenalidomide, specifically focusing on a stable composition that comprises anhydrous Lenalidomide Form I along with one or more pharmaceutically acceptable excipients. The patent also details the process for preparing such compositions.

Career Highlights

Vemuri Venkata Suresh Babu is associated with Natco Pharma Limited, a prominent player in the pharmaceutical industry. His work at Natco Pharma has allowed him to contribute to the development of innovative pharmaceutical solutions.

Collaborations

He has collaborated with notable coworkers, including Vattikuti Satyanarayana and Bhavanasi Krishna Murthy, to further enhance the research and development efforts within the company.

Conclusion

Vemuri Venkata Suresh Babu's contributions to pharmaceutical compositions exemplify the importance of innovation in the healthcare sector. His work continues to impact the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…